4Gallego A ,Baron M ,Arranz E. Oxycodone: a pharmacological and clinical review [ J ]. Clin Transl Oneol,2007,9 ( 5 ) : 298 - 307.
5Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatmenl of cancer pain: evidence-based recommendations from the EAPC [ J ]. Lancet Onco1,2012,13 (2) : e58 - e68.
8Wensel T, Powe K, Cates M. Pregabalin for the treatment of gener- alized anxiety disorder [ J ]. Ann Pharmacother, 2012,46 : 424 - 429.
9Anastassopoulos K, Chow W, Ackerman S, et al. Oxycodonerelated side effects :impact on degree of bother, adherence, pain relief, sat- isfaction, and quality of life [ J ]. J Opioid Manag,2011,7 ( 3 ) : 203 -215.
10Ishiham M, Ikesue H, Matsunaga H, et al. A muhi-institutionai study analyzing effect of prophylactic medication for prevention of upioid-induced gastrointestinal dysfunc4ion[ J]. ClinJ Pain ,2012, 28(5) :373 -381.
5Goudas LC, Bloch R, Gialeli-Goudas M, et al. The epidemiology of cancer pain [ J ] . Cancer Invest, 2005, 23:182-190.
6Svendsen KB, Andersen S, Arnason S, et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms [ J ] . Eur J Pain, 2005, 9:195-206.
7Dhingra L, Lam K, Homel P, et al. Pain in underserved community-dwelling Chinese American cancer patients:demogtaphic and medical.correlates[J].Oncologisl, 2011, 16:523-533.
8Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes [ J ] . Ann Onc, 2009, 20:1420-1433.
9Thapa D, Rastogi V, Ahuja V. Cander pain management-current status [ J ] . J Anaesthesiol Clin Pharmacol, 2011, 27:162-165.
10Greene ER, Huang S, Serhan CN, et al. Regulation of inflammation in cancer by eicosanoids [ J ] . Prostaglandins Other Lipid Medial, 2011, 96:27-36.
6Stjernsward J. WHO cancer pain relief programme [J]. Cancer Surv, 1988,7(1 ) : 195-208.
7Stjernsward J, Colleau SM,Ventafridda V. The World Health Organization Cancer Pain and Palliative Care Program. Past,present, and future [J]. J Pain Symptom Manage, 1996, 12(2) :65-72.
9Nakamura A,Hasegawa M,Minami K,et al. Differential activetion of the mopioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model [J]. British Journal of Pharmacology, 2013,168 : 375-388.
10Wang YM,Liu ZW, Liu JL, et al. Efficacy and tolerability of oxy-codone inmoderate-severe cancer related pain: a meta analysis of randomized controlled trials [J]. Exp Ther Med, 2012,4(2) : 249-254.
